共 50 条
- [2] Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E-Mutated Erdheim-Chester Disease: A Case Report [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
- [3] Encorafenib for Erdheim-Chester disease harboring the BRAFV600E mutation [J]. ANNALS OF ONCOLOGY, 2021, 32 : S359 - S359
- [4] FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim-Chester Disease with the BRAFV600 Mutation [J]. ONCOLOGIST, 2018, 23 (12): : 1520 - 1524
- [6] Significant response to dabrafenib in a patient with Erdheim-Chester disease with BRAFV600E mutation [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (06): : 386 - 388
- [7] Sirolimus monotherapy for Erdheim-Chester disease [J]. ACTA ONCOLOGICA, 2019, 58 (06) : 901 - 905
- [8] Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib [J]. BIOLOGY-BASEL, 2023, 12 (04):